This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Molina Healthcare (MOH) Tops Q2 Earnings, Updates '18 View
by Zacks Equity Research
Molina Healthcare's (MOH) Q2 gains from a decline in expense. The company also revises its full-year guidance.
Molina (MOH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 106.42% and 4.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Revenue Growth Drive Teladoc (TDOC) Q2 Earnings Higher?
by Zacks Equity Research
Teladoc (TDOC) Q2 earnings to gain from increased patient visits and subscription fees.
Centene (CNC) Beats Q2 Earnings Estimates, Revises Guidance
by Zacks Equity Research
Centene's (CNC) second-quarter earnings beat on revenue and membership growth. The top line improves owing to Health Insurance Marketplace business, acquisitions and expansions.
Anthem (ANTM) Q2 Earnings: Is a Beat in Store for the Stock?
by Zacks Equity Research
Anthem's (ANTM) second-quarter earnings are likely to gain from the solid performance of its Government Business and Commercial & Specialty Business segments.
UnitedHealth's (UNH) Q2 Earnings Beat, 2018 Guidance Up
by Zacks Equity Research
UnitedHealth (UNH) Q2 earnings beat on membership growth, 2018 guidance pulled up.
Will Higher Revenues Aid UnitedHealth's (UNH) Q2 Earnings?
by Zacks Equity Research
Continued strong performance across the company to aid UnitedHealth's (UNH) results.
Humana (HUM) Jointly Buys Curo, Boosts Medicare Business
by Zacks Equity Research
Humana (HUM) completes its joint acquisition of Curo with WCAS to expand its Medicare Advantage business.
UnitedHealth's Unit to Provide Better Care in North Carolina
by Zacks Equity Research
UnitedHealth's (UNH) arm forges an alliance with Community Care for providing better and cost-efficient care in North Carolina.
The Zacks Analyst Blog Highlights: Micron Technology, ArcBest, Marathon Oil, Azure Power Global and Molina Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Micron Technology, ArcBest, Marathon Oil, Azure Power Global and Molina Healthcare
The Big Banks Report: Global Week Ahead
by John Blank
Financials stocks won big from the tax cuts ??? their Q1 bottom lines were possibly fattened by as much as $5 billion. Thomson Reuters I/B/E/S forecast banks' Q2 growth at 22 percent.
Humana (HUM) Hits 52-Week High, Is Further Upside Left?
by Zacks Equity Research
Riding high on Kindred Healthcare acquisition and a recent rating affirmation, Humana's (HUM) shares reach a 52-week high on July 6.
Will Insurers Suffer on Halt in Risk-Adjustment Payment?
by Sapna Bagaria
The most-recent regulatory action to halt risk-adjustment payments should pose uncertainty for health insurers.
5 Stocks to Buy as Markets Are Shrugging Off Trade War Fears
by Sweta Killa
A number of Wall Street strategists remained bullish about the outlook for American equities given the expectations of double-digit earnings growth, accelerated buybacks, pro-business policies, historic tax cuts and a strong labor market.
WCG Vs. MOH: Which Health Insurance Stock is Better Placed
by Zacks Equity Research
Wellcare and Molina are both poised to grow in a thriving health insurance industry, but one has an edge over the other.
Ensign Boosts Skilled Nursing Facility With McCall Buyout
by Zacks Equity Research
Ensign's (ENSG) acquisition of McCall reflects its strategy to expand in the growing skilled nursing market.
Humana Jointly Acquires Kindred, Expands Into Patient Care
by Zacks Equity Research
Humana (HUM) jointly acquires Kindred to expand its geographical presence.
Centene (CNC) to Tap New York Market Through Fidelis Care
by Zacks Equity Research
Centene (CNC) acquires Fidelis Care for $3.75 billion. This strategic move is likely to help expand the company's footprint across the state of New York.
4 Top Health Insurance Stocks of 1H With Room to Run in 2H
by Sapna Bagaria
Rise in membership, revenue diversification, healthy balance sheet and cost control are behind the strong performance in 1H.
Zacks Industry Outlook Highlights: WellCare, Molina, Humana and Anthem
by Zacks Equity Research
Zacks Industry Outlook Highlights: WellCare, Molina, Humana and Anthem
New Strong Buy Stocks for June 29th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Health Insurance Stock Outlook: Unstoppable Growth Ahead
by Zacks Equity Research
The retiring baby boomer population, new revenue streams, consolidation and a healthy economy paints a bright picture for the health insurance industry.
Molina Healthcare to Sell MMS Unit for Business Streamlining
by Zacks Equity Research
Molina Healthcare's (MOH) impending sale of its unit is in line with its business restructuring initiatives.
UnitedHeathcare Arm Gets Charge of Kansas Medicaid Program
by Zacks Equity Research
The State of Kansas picks UnitedHealth Group (UNH) arm for administering the statewide Medicaid Program.
Molina Healthcare Hits 52 Week High: Is Further Upside Left?
by Zacks Equity Research
Molina Healthcare's (MOH) receipt of Florida Medicaid contract and a clearer visibility on its turnaround initiatives appear to appreciate its stock price.